COMMUNIQUÉS West-GlobeNewswire
 
      -   
  Holding(s) in Company09/01/2019
-   
  Medtronic Foundation Recognizes 12 Bakken Invitation Honorees for Driving Positive Change in Healthcare09/01/2019
-   
  Results-Based Outsourcing Inc., Announces Name Change to Driven Inc.09/01/2019
-   
  Intuitive Surgical Announces Preliminary Fourth Quarter and Full Year 2018 Results09/01/2019
-   
  Dr. Jeffrey D. Gross of Newport Beach, CA Now Offering Free Virtual Second Opinion Consultations for Surgery09/01/2019
-   
  UPDATE -- Moving forward with Cannabis Sales License, Abba Medix Eyes EU-GMP Certification, Signs Agreement with Cannabis OneFive, Inc.09/01/2019
-   
  Two Marrone Bio Innovations products, MBI-110 Biofungicide and Haven Sunprotectant, approved for sale in Canada09/01/2019
-   
  Sharps Compliance Announces Second Quarter Fiscal 2019 Conference Call and Webcast09/01/2019
-   
  Wildflower Experience Shop-in-Shop Retail Launches in New York City09/01/2019
-   
  Exclusive Interview: Lexaria CEO Discusses Progress & Plans at O’Cannabiz 2018 -- CFN Media09/01/2019
-   
  OncBioMune Announces Former Puma Biotechnology Executive and Genentech Veteran Brian Barnett, M.D., as Chief Executive Officer09/01/2019
-   
  Moving forward with Cannabis Sales License, Abba Medix Eyes EU-GMP Certification, Signs Agreement with Cannabis OneFive, Inc.09/01/2019
-   
  Southeastern Grocers Partner with eTrueNorth to Launch CLIA-waived Laboratory for Point-of-Care Testing at Local Pharmacies09/01/2019
-   
  Acasti Pharma Awarded Broad Composition-of-Matter and Method of Use Patents by the European Patent Office09/01/2019
-   
  CareDx to Present New AlloSure® Data at American Society of Transplant Surgeons Winter Symposium09/01/2019
-   
  Pluristem Therapeutics Reports Successful Case Study in Treatment of Buerger’s Disease Patient09/01/2019
-   
  Cancer Genetics Strengthens Management Team with Appointment of William Finger as Executive Vice President, Precision Medicine and Pharma Services09/01/2019
-   
  Verona Pharma Receives WHO Approval for “ensifentrine” as Recommended INN for RPL55409/01/2019
-   
  Rafael Pharmaceuticals Announces Initiation of Phase II Trial of CPI-613 in Combination with Modified FOLFIRINOX in Locally Advanced Pancreatic Cancer09/01/2019
Pages